Current status and development direction of hyperbaric medicine in Korea
Open Access
- 10 April 2022
- journal article
- research article
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 65 (4) , 232-238
Abstract
Background: The indications of hyperbaric oxygen therapy (HBOT) covered by the health insurance in Korea increased to 16 in 2019, which includes acute central retinal artery obstruction within 24 hours of vision loss; anemia due to excessive bleeding, since blood transfusion is impractical; chronic refractory osteomyelitis (Wagner grade ≥3); and intracranial abscess.Current Concepts: HBOT affects the treatment in the primary and secondary mechanisms. According to the Boyle’s law, the primary mechanism is important in treating decompression sickness and intravascular air embolism by decreasing the volume of air bubbles when pressure increases, whereas the secondary mechanism involves hyperoxygenation of the primary mechanism and various effects, such as vasoconstriction, angiogenesis, immune function enhancement, reperfusion injury prevention, antimicrobial action, and gas washout effect, occur. In the past 5 years, domestic HBOT has made significant progress. However, there are many non-therapeutic lowpressure HBOT facilities that are limited by insurance coverage issues, quality equipment management, and medical personnel in HBOT facilities.Discussion and Conclusion: To solve the problem, the introduction of the definition of therapeutic hyperbaric pressure and certification system of HBOT facilities must be initiated. Moreover, the system should be improved so that insurance can be applied for a more indication of HBOT.Keywords
This publication has 13 references indexed in Scilit:
- Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow–derived cellsBlood, 2005
- Hyperbaric oxygen after global cerebral ischemia in rabbits does not promote brain lipid peroxidationCritical Care Medicine, 1995
- Role of oxygen in phagocyte microbicidal action.Environmental Health Perspectives, 1994
- Oxygen Tensions and Infections: Modulation of Microbial Growth, Activity of Antimicrobial Agents, and Immunologic ResponsesClinical Infectious Diseases, 1992
- Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1991
- Oxygen-dependent antagonism of lipid peroxidationFree Radical Biology and Medicine, 1991
- Oxygen-dependent differences in exopolysaccharide production and aminoglycoside inhibitory-bactericidal interactions with Pseudomonas aeruginosa—implications for endocarditisJournal of Antimicrobial Chemotherapy, 1989
- Bacterial osteomyelitis: Adjunctive hyperbaric oxygen therapyInfectious Diseases Newsletter, 1984
- Treatment of Experimental Chronic Osteomyelitis Due to Staphylococcus aureus with Vancomycin and RifampinThe Journal of Infectious Diseases, 1983
- Therapy with Hyperbaric Oxygen for Experimental Osteomyelitis Due to Staphylococcus aureus in RabbitsThe Journal of Infectious Diseases, 1978